AI-powered search
Try Polaris, our new AI-powered search!

What monitoring is recommended for routine patient management with bimekizumab to assess liver enzyme levels?

Featuring April Armstrong, MD, MPH | Co-Director |

Chief, Division of Dermatology
David Geffen School of Medicine at UCLA
Los Angeles, CA

| Published January 01, 2024

More from this series